Guillaume Alexandre Pascal Rizk

Title: Innovations by Guillaume Alexandre Pascal Rizk

Introduction

Guillaume Alexandre Pascal Rizk is a notable inventor based in Rennes, France. He has made significant contributions to the field of genomic data processing, holding a total of 7 patents. His work focuses on enhancing the efficiency and accuracy of genomic read mapping and data compression.

Latest Patents

Rizk's latest patents include a "Multi-pass software-accelerated genomic read mapping engine." This invention describes methods, systems, and apparatuses, including computer programs encoded on computer-storage media, for software-accelerated genomic data read mapping. The process involves obtaining a first k-mer seed from a genomic data read, generating a genomic signature based on that seed, and determining a reference sequence location using a hash data structure. Additionally, it addresses the number of mismatches and selects an actual alignment for the genomic data read based on a set of k-mer seeds.

Another significant patent is related to "Quality score compression." This invention outlines methods, systems, and computer programs for compressing nucleic acid sequence data. The method includes obtaining nucleic acid sequence data that represents a read sequence and a plurality of quality scores. It determines whether the read sequence includes at least one 'N' base and generates a first encoding data set by encoding each set of four quality scores into a single byte of memory, thereby compressing the data effectively.

Career Highlights

Guillaume Rizk is currently associated with Illumina Corporation, a leading company in the field of genomics. His role at Illumina allows him to contribute to cutting-edge research and development in genomic technologies.

Collaborations

Due to space constraints, the details of collaborations will not be included.

Conclusion

Guillaume Alexandre Pascal Rizk is a prominent inventor whose work in genomic data processing has led to significant advancements in the field. His innovative patents reflect his commitment to improving genomic technologies and data management.